methamphetamine has been researched along with u 69593 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chefer, V; El Daly, E; Sandill, S; Shippenberg, TS | 1 |
| Hanson, GR; Johnson-Davis, KL; Keefe, KA | 1 |
2 other study(ies) available for methamphetamine and u 69593
| Article | Year |
|---|---|
Modulation of the neurotoxic effects of methamphetamine by the selective kappa-opioid receptor agonist U69593.
Topics: Analgesics; Animals; Benzeneacetamides; Body Temperature; Brain Chemistry; Dopamine; Dopamine Agents; Drug Interactions; Fever; Male; Methamphetamine; Mice; Microdialysis; Potassium; Pyrrolidines; Receptors, Opioid, kappa | 2000 |
Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amphetamine-Related Disorders; Analgesics; Analgesics, Non-Narcotic; Animals; Benzeneacetamides; Brain Chemistry; Central Nervous System Stimulants; Dopamine; Male; Methamphetamine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Serotonin | 2003 |